Hepatitis C in asymptomatic blood donors. 1997

H J Alter, and C Conry-Cantilena, and J Melpolder, and D Tan, and M Van Raden, and D Herion, and D Lau, and J H Hoofnagle
Department of Transfusion Medicine, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892-1184, USA.

Among 248 asymptomatic blood donors positive for antibody to hepatitis C virus (anti-HCV) enrolled in a long-term prospective study, 86% had chronic HCV infection and 14% appeared to have recovered as assessed by serial determinations of serum alanine aminotransferase (ALT) levels and HCV RNA by polymerase chain reaction. Established parenteral risk factors for HCV transmission were identified in 75% of donors. In addition, there was a strong independent association between HCV positivity and cocaine snorting, suggesting that shared snorting devices may be a covert route of parenteral transmission. Ear piercing in males was also significantly associated with transmission. There was no evidence for sexual spread. Although the majority of HCV carriers had both biochemical and histological evidence of chronic viral hepatitis, the extent of liver injury was generally mild. Among a larger population of 280 HCV RNA-positive donors, 17% had repeatedly normal ALT levels, 45% had levels that did not exceed twice, and only 22% had levels that exceeded five times the upper limit of the normal range. Among 81 patients who underwent liver biopsy, only 13% had evidence of severe hepatitis (8%) or cirrhosis (5%), despite a duration of infection that generally exceeded 15 years. No severe histological lesions were observed in blood donors with chronic HCV infection who had repeatedly normal ALT levels. In both donors and blood recipients, the frequency of severe morbidity or mortality related to HCV infection was less than 10% during the first two decades of infection. Further long-term studies are required to see if the progression to severe outcomes continues to accrue at this slow pace or whether it accelerates during subsequent decades.

UI MeSH Term Description Entries
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D014766 Viremia The presence of viruses in the blood. Viremias
D018937 Hepatitis C Antibodies Antibodies to the HEPATITIS C ANTIGENS including antibodies to envelope, core, and non-structural proteins. Anti-HCV Antibodies,Anti-Hepatitis C Virus Antibodies,HCV Antibodies,Hepatitis C Virus Antibodies,Anti HCV Antibodies,Anti Hepatitis C Virus Antibodies

Related Publications

H J Alter, and C Conry-Cantilena, and J Melpolder, and D Tan, and M Van Raden, and D Herion, and D Lau, and J H Hoofnagle
April 1995, BMJ (Clinical research ed.),
H J Alter, and C Conry-Cantilena, and J Melpolder, and D Tan, and M Van Raden, and D Herion, and D Lau, and J H Hoofnagle
October 1994, BMJ (Clinical research ed.),
H J Alter, and C Conry-Cantilena, and J Melpolder, and D Tan, and M Van Raden, and D Herion, and D Lau, and J H Hoofnagle
January 2018, Pakistan journal of medical sciences,
H J Alter, and C Conry-Cantilena, and J Melpolder, and D Tan, and M Van Raden, and D Herion, and D Lau, and J H Hoofnagle
April 1995, Schweizerische medizinische Wochenschrift,
H J Alter, and C Conry-Cantilena, and J Melpolder, and D Tan, and M Van Raden, and D Herion, and D Lau, and J H Hoofnagle
April 1993, Australian and New Zealand journal of medicine,
H J Alter, and C Conry-Cantilena, and J Melpolder, and D Tan, and M Van Raden, and D Herion, and D Lau, and J H Hoofnagle
January 1994, Vox sanguinis,
H J Alter, and C Conry-Cantilena, and J Melpolder, and D Tan, and M Van Raden, and D Herion, and D Lau, and J H Hoofnagle
January 1995, BMJ (Clinical research ed.),
H J Alter, and C Conry-Cantilena, and J Melpolder, and D Tan, and M Van Raden, and D Herion, and D Lau, and J H Hoofnagle
March 1993, Lancet (London, England),
H J Alter, and C Conry-Cantilena, and J Melpolder, and D Tan, and M Van Raden, and D Herion, and D Lau, and J H Hoofnagle
November 2004, Journal of viral hepatitis,
H J Alter, and C Conry-Cantilena, and J Melpolder, and D Tan, and M Van Raden, and D Herion, and D Lau, and J H Hoofnagle
June 1994, Histopathology,
Copied contents to your clipboard!